196 related articles for article (PubMed ID: 27860402)
1. Characterization of a Cell-Penetrating Peptide with Potential Anticancer Activity.
Gronewold A; Horn M; Ranđelović I; Tóvári J; Muñoz Vázquez S; Schomäcker K; Neundorf I
ChemMedChem; 2017 Jan; 12(1):42-49. PubMed ID: 27860402
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine anti-proliferative activity significantly enhanced upon conjugation with cell-penetrating peptides.
Vale N; Ferreira A; Fernandes I; Alves C; Araújo MJ; Mateus N; Gomes P
Bioorg Med Chem Lett; 2017 Jul; 27(13):2898-2901. PubMed ID: 28495087
[TBL] [Abstract][Full Text] [Related]
3. Cell-penetrating peptide conjugates of gambogic acid enhance the antitumor effect on human bladder cancer EJ cells through ROS-mediated apoptosis.
Lyu L; Huang LQ; Huang T; Xiang W; Yuan JD; Zhang CH
Drug Des Devel Ther; 2018; 12():743-756. PubMed ID: 29670331
[TBL] [Abstract][Full Text] [Related]
4. Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties.
Soler M; González-Bártulos M; Soriano-Castell D; Ribas X; Costas M; Tebar F; Massaguer A; Feliu L; Planas M
Org Biomol Chem; 2014 Mar; 12(10):1652-63. PubMed ID: 24480922
[TBL] [Abstract][Full Text] [Related]
5. Novel cleavable cell-penetrating peptide-drug conjugates: synthesis and characterization.
Lelle M; Frick SU; Steinbrink K; Peneva K
J Pept Sci; 2014 May; 20(5):323-33. PubMed ID: 24677287
[TBL] [Abstract][Full Text] [Related]
6. Cell-Penetrating Peptide-Conjugated BF
Laxman K; Reddy BPK; Robinson A; Srivastava R; Ravikanth M
ChemMedChem; 2020 Oct; 15(19):1783-1787. PubMed ID: 32726512
[TBL] [Abstract][Full Text] [Related]
7. Delivering aminopyridine ligands into cancer cells through conjugation to the cell-penetrating peptide BP16.
Soler M; González-Bártulos M; Figueras E; Massaguer A; Feliu L; Planas M; Ribas X; Costas M
Org Biomol Chem; 2016 Apr; 14(17):4061-70. PubMed ID: 27055538
[TBL] [Abstract][Full Text] [Related]
8. Screening and characterization of a novel high-efficiency tumor-homing cell-penetrating peptide from the buffalo cathelicidin family.
Xu YY; Cao XW; Fu LY; Zhang TZ; Wang FJ; Zhao J
J Pept Sci; 2019 Sep; 25(9):e3201. PubMed ID: 31309656
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and cellular characterization of various nano-assemblies of cell penetrating peptide-epirubicin-polyglutamate conjugates for the enhancement of antitumor activity.
Mohammadi S; Zakeri-Milani P; Golkar N; Farkhani SM; Shirani A; Shahbazi Mojarrad J; Nokhodchi A; Valizadeh H
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1572-1585. PubMed ID: 28933182
[TBL] [Abstract][Full Text] [Related]
10. Effect of Ala replacement with Aib in amphipathic cell-penetrating peptide on oligonucleotide delivery into cells.
Wada S; Hashimoto Y; Kawai Y; Miyata K; Tsuda H; Nakagawa O; Urata H
Bioorg Med Chem; 2013 Dec; 21(24):7669-73. PubMed ID: 24216093
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis reveals amino acids critical for anticancer activity of peptide CIGB-552.
Astrada S; Gomez Y; Barrera E; Obal G; Pritsch O; Pantano S; Vallespí MG; Bollati-Fogolín M
J Pept Sci; 2016 Nov; 22(11-12):711-722. PubMed ID: 27933724
[TBL] [Abstract][Full Text] [Related]
12. Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide.
Jones S; Howl J
Bioconjug Chem; 2012 Jan; 23(1):47-56. PubMed ID: 22148546
[TBL] [Abstract][Full Text] [Related]
13. Increasing the potential of cell-penetrating peptides for cancer therapy using a new pentagonal scaffold.
Duarte D; Fraga AG; Pedrosa J; Martel F; Vale N
Eur J Pharmacol; 2019 Oct; 860():172554. PubMed ID: 31326378
[TBL] [Abstract][Full Text] [Related]
14. Peptide internalization enabled by folding: triple helical cell-penetrating peptides.
Shinde A; Feher KM; Hu C; Slowinska K
J Pept Sci; 2015 Feb; 21(2):77-84. PubMed ID: 25524829
[TBL] [Abstract][Full Text] [Related]
15. Cell Penetrating Capacity and Internalization Mechanisms Used by the Synthetic Peptide CIGB-552 and Its Relationship with Tumor Cell Line Sensitivity.
Astrada S; Fernández Massó JR; Vallespí MG; Bollati-Fogolín M
Molecules; 2018 Mar; 23(4):. PubMed ID: 29601540
[TBL] [Abstract][Full Text] [Related]
16. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, and Evaluation of Homochiral Peptides Containing Arginine and Histidine as Molecular Transporters.
El-Sayed NS; Miyake T; Shirazi AN; Park SE; Clark J; Buchholz S; Parang K; Tiwari R
Molecules; 2018 Jun; 23(7):. PubMed ID: 29966296
[TBL] [Abstract][Full Text] [Related]
18. Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity.
Drexelius M; Reinhardt A; Grabeck J; Cronenberg T; Nitsche F; Huesgen PF; Maier B; Neundorf I
Biochem J; 2021 Jan; 478(1):63-78. PubMed ID: 33313751
[TBL] [Abstract][Full Text] [Related]
19. Enhancing antitumor activity of silver nanoparticles by modification with cell-penetrating peptides.
Mussa Farkhani S; Asoudeh Fard A; Zakeri-Milani P; Shahbazi Mojarrad J; Valizadeh H
Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):1029-1035. PubMed ID: 27357085
[TBL] [Abstract][Full Text] [Related]
20. Thermosensitive magnetic liposomes with doxorubicin cell-penetrating peptides conjugate for enhanced and targeted cancer therapy.
Lin W; Xie X; Yang Y; Fu X; Liu H; Yang Y; Deng J
Drug Deliv; 2016 Nov; 23(9):3436-3443. PubMed ID: 27193383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]